Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Soralex** is an Ecuadorian multi-ingredient topical exfoliating cream developed by Laboratory José F. Quiróz Pérez and La Salud Pharmacy for mild-to-moderate psoriasis. The fixed topical formulation contains salicylic acid, sublimated sulfur, potassium aluminum sulfate, bay essential oil, animal lard, and petroleum jelly. Its intended activity combines salicylic-acid keratolysis to reduce adherent scale, antimicrobial effects attributed to sulfur, astringent and skin-healing effects attributed to potassium aluminum sulfate, and emollient barrier support from the lipid-based vehicle. A reported randomized controlled clinical study in Ecuador evaluated twice-daily use for 10 days in patients with psoriasis and described reductions in erythema, infiltration, desquamation, pruritus, PASI, and affected body-surface area.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Soralex (Laboratorio José F. Quiróz Pérez).